Variables | Crude OR [95%CI] | p-value | Adjusted OR [95%CI]a | p-value |
---|---|---|---|---|
Gender (male vs female) | 1.3 [0.7–2.4] | 0.353 | 1.3 [0.6–2.8] | 0.430 |
Attended school | ||||
 No | 0.8 [0.4–1.6] | 0.530 | 1.7 [0.5–5.2] | 0.365 |
 Yes | 1 |  |  |  |
Co-morbidity | ||||
 Yes | 8.5 [3.3–22.1] | 0.000b | 10.3 [3.8–28.3] | 0.000b |
 No | 1 |  | 1 |  |
Type of anti-hypertensive drugs | ||||
 Multitherapy | 4.9 [1.4–16.6] | 0.011b | 4.6 [1.3–16.1] | 0.017b |
 No treatment | 0.8 [0.4–1.6] | 0.446 | 0.6 [0.3–1.3] | 0.199 |
 Monotherapy | 1 |  | 1 |  |
Experience of side effects | ||||
 Yes | 1.0 [0.4–2.5] | 0.965 | 1.1 [0.4–3.1] | 0.786 |
 No | 1 |  |  |  |
Treatment adherence | ||||
 No | 0.9 [0.4–1.6] | 0.658 | 0.9 [0.4–1.7] | 0.658 |
 Yes | 1 |  |  |  |
Time given by HCP | ||||
 Insufficient | 1.1 [0.4–2.9] | 0.827 | 0.6 [0.2–2.0] | 0.390 |
 Sufficient | 1 |  |  |  |
Type of HCF | ||||
 HC | 1.1 [0.6–1.9] | 0.768 | 0.6 [0.3–1.2] | 0.160 |
 GRH | 1 |  | 1 |  |